206A.T
Price:
$141
Market Cap:
$5.21B
PRISM BioLab Co., LTD. engages in the research and development of pharmaceuticals using its proprietary drug discovery platform, PepMetics Technology. The company's technology focuses on creating peptide mimetic small molecules designed to mimic α-helix or β-turn peptides, which are essential for protein-protein interactions. Through its platform, PRISM aims to discover drugs for what were previously considered 'undruggable targets,' with a pipeline including candidates for cancer and fibrotic diseases.
Industry
Biotechnology
IPO Date
2024-07-02
Stock Exchange
JPX
Ticker
206A.T
According to PRISM BioLab Co.,LTD’s latest financial reports and current stock price. The company's current PE Ratio is -5.95. This represents a change of -64.78% compared to the average of -16.90 of the last 4 quarters.
The mean historical PE Ratio of PRISM BioLab Co.,LTD over the last ten years is 56.70. The current -5.95 PE Ratio has changed -1149.30% with respect to the historical average. Over the past ten years (40 quarters), 206A.T's PE Ratio was at its highest in in the March 2024 quarter at 0. The PE Ratio was at its lowest in in the September 2025 quarter at -51.85.
Average
56.70
Median
-9.79
Minimum
-29.81
Maximum
276.21
Discovering the peaks and valleys of PRISM BioLab Co.,LTD PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 0%
Maximum Annual PE Ratio = 276.21
Minimum Annual Increase = -110.79%
Minimum Annual PE Ratio = -29.81
| Year | PE Ratio | Change |
|---|---|---|
| 2025 | -7.36 | -39.79% |
| 2024 | -12.23 | -58.98% |
| 2023 | -29.81 | -110.79% |
The current PE Ratio of PRISM BioLab Co.,LTD (206A.T) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
-16.47
5-year avg
56.70
10-year avg
56.70
PRISM BioLab Co.,LTD’s PE Ratio is greater than D. Western Therapeutics Institute, Inc. (-6.05), less than Delta-Fly Pharma, Inc. (-0.81), less than BrightPath Biotherapeutics Co., Ltd. (-3.60), less than Ribomic Inc. (-3.28), less than Carna Biosciences, Inc. (-3.67), greater than TMS Co., Ltd. (-6.56), less than Modalis Therapeutics Corporation (-1.29), less than Soiken Holdings Inc. (26.97), greater than Cyfuse Biomedical K.K. (-7.85), greater than Noile-Immune Biotech Inc. (-6.55),
| Company | PE Ratio | Market cap |
|---|---|---|
| -6.05 | $4.14B | |
| -0.81 | $1.55B | |
| -3.60 | $3.86B | |
| -3.28 | $4.20B | |
| -3.67 | $7.85B | |
| -6.56 | $5.92B | |
| -1.29 | $2.99B | |
| 26.97 | $5.73B | |
| -7.85 | $6.45B | |
| -6.55 | $4.94B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like PRISM BioLab Co.,LTD using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like PRISM BioLab Co.,LTD or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is PRISM BioLab Co.,LTD's PE Ratio?
How is the PE Ratio calculated for PRISM BioLab Co.,LTD (206A.T)?
What is the highest PE Ratio for PRISM BioLab Co.,LTD (206A.T)?
What is the 3-year average PE Ratio for PRISM BioLab Co.,LTD (206A.T)?
What is the 5-year average PE Ratio for PRISM BioLab Co.,LTD (206A.T)?
How does the current PE Ratio for PRISM BioLab Co.,LTD (206A.T) compare to its historical average?